Personally, I am a little relieved that it looks like the uplisting might be postponed a while. The sooner we get off the OTC the better, but I really was not looking forward to a possible 20/1 RS.
I would much prefer to have the pipeline move further along and uplist when the pps is around .50c or so even if it means waiting a few more months.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links